uniQure (QURE) Accumulated Expenses (2015 - 2026)
uniQure (QURE) recorded quarterly Accumulated Expenses of $43.2 million in Q1 2026, up 4.62% quarter-over-quarter from $41.3 million in Q4 2025, and up 295.58% on a YoY basis from $10.9 million in Q1 2025.
uniQure (QURE) Accumulated Expenses (2015 - 2026) Analysis & Trends
uniQure's Accumulated Expenses history runs 12 years deep, the most recent figure standing at $43.2 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 295.58% year-over-year to $43.2 million; the TTM figure through Mar 2026 stood at $43.2 million (up 295.58% YoY), while the FY2025 annual figure was $41.3 million, up 235.98% from the prior year.
- Accumulated Expenses was $43.2 million for Q1 2026 at uniQure, up from $41.3 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $51.9 million in Q3 2025 to a low of $7.9 million in Q2 2022.
- Historically, Accumulated Expenses has averaged $23.2 million across 5 years, with a median of $22.5 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Accumulated Expenses tumbled 51.8% in 2025, then soared 295.58% in 2026.
- A 5-year view of Accumulated Expenses shows it stood at $30.6 million in 2022, then plunged by 46.8% to $16.3 million in 2023, then fell by 24.43% to $12.3 million in 2024, then jumped by 235.98% to $41.3 million in 2025, then climbed by 4.62% to $43.2 million in 2026.
- The last three Accumulated Expenses figures came in at $43.2 million (Q1 2026), $41.3 million (Q4 2025), and $51.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.20 Mn |
| Dec 31, 2025 | 41.29 Mn |
| Sep 30, 2025 | 51.95 Mn |
| Jun 30, 2025 | 31.48 Mn |
| Mar 31, 2025 | 10.92 Mn |
| Dec 31, 2024 | 12.29 Mn |
| Sep 30, 2024 | 15.44 Mn |
| Jun 30, 2024 | 11.02 Mn |
| Mar 31, 2024 | 22.66 Mn |
| Dec 31, 2023 | 16.26 Mn |
| Sep 30, 2023 | 28.43 Mn |
| Jun 30, 2023 | 12.31 Mn |
| Mar 31, 2023 | 22.53 Mn |
| Dec 31, 2022 | 30.57 Mn |
| Sep 30, 2022 | 26.44 Mn |
| Jun 30, 2022 | 7.85 Mn |
| Mar 31, 2022 | 9.60 Mn |
| Dec 31, 2021 | 28.49 Mn |
| Sep 30, 2021 | 30.75 Mn |
| Jun 30, 2021 | 6.79 Mn |